The role of quercetin on the survival of neuron-like PC12 cells and the expression of α-synuclein

Neural Regeneration Research
Tae-Beom Ahn, Beom S Jeon

Abstract

Both genetic and environmental factors are important in the pathogenesis of Parkinson's disease. As α-synuclein is a major constituent of Lewy bodies, a pathologic hallmark of Parkinson's disease, genetic aspects of α-synuclein is widely studied. However, the influence of dietary factors such as quercetin on α-synuclein was rarely studied. Herein we aimed to study the neuroprotective role of quercetin against various toxins affecting apoptosis, autophagy and aggresome, and the role of quercetin on α-synuclein expression. PC12 cells were pre-treated with quercetin (100, 500, 1,000 μM) and then together with various drugs such as 1-methyl-4-phenylpyridinium (MPP(+); a free radical generator), 6-hydroxydopamine (6-OHDA; a free radical generator), ammonium chloride (an autophagy inhibitor), and nocodazole (an aggresome inhibitor). Cell viability was determined using a 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltertazolium bromide (MTT) assay. Apoptosis was detected by annexin V-fluorescein isothiocyanate and propidium iodide through the use of fluorescence activated cell sorter. α-Synuclein expression was detected by western blot assay and immunohistochemistry. The role of α-synuclein was further studied by knocking out α-synuclein u...Continue Reading

References

Nov 12, 1990·FEBS Letters·T P Singer, R R Ramsay
Nov 15, 1996·Science·M H PolymeropoulosR C Duvoisin
Jan 1, 1997·Journal of Neural Transmission. Supplementum·Y GlinkaM B Youdim
Aug 28, 1997·Nature·M G SpillantiniM Goedert
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
Sep 12, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ji-Heui SeoYoo-Hun Suh
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Aug 4, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Seonghan KimYoo-Hun Suh
Sep 29, 2004·Lancet·Marie-Christine Chartier-HarlinAlain Destée
Nov 5, 2005·Cell·Sreeganga ChandraThomas C Südhof
Jul 14, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yan Leng, De-Maw Chuang
Jun 29, 2007·Plant Foods for Human Nutrition·P MullieM Hebbelinck
Jan 12, 2008·Brain : a Journal of Neurology·Tianhong PanJoseph Jankovic
Jul 8, 2008·The Journal of Nutritional Biochemistry·Mubeen Ahmad AnsariD Allan Butterfield
Oct 2, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·Stephan C Bischoff
Apr 16, 2009·Forum of Nutrition·Junji Terao
Jun 23, 2009·Expert Opinion on Drug Safety·Bernardino OssolaPekka T Männistö
Feb 26, 2010·Journal of Alzheimer's Disease : JAD·João CostaAntónio Vaz-Carneiro
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·David Sulzer
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jan BieschkeErich E Wanker
Apr 28, 2010·Human Molecular Genetics·Mark R Cookson, Oliver Bandmann
Apr 5, 2011·Parkinsonism & Related Disorders·Keiko TanakaUNKNOWN Fukuoka Kinki Parkinson's Disease Study Group
Jan 26, 2012·Diabetes·Eijiro Yamada, Rajat Singh
Mar 7, 2012·Journal of Molecular Neuroscience : MN·Han-Joon KimKwang-Woo Lee
May 25, 2012·Molecular Neurobiology·Koichi WakabayashiHitoshi Takahashi
Jan 9, 2013·Biochimica Et Biophysica Acta·Min ZhuAnthony L Fink
Sep 6, 2014·Frontiers in Molecular Neuroscience·Gorica RisticSokol V Todi
Nov 30, 2014·Neurologic Clinics·Stephen Mullin, Anthony H V Schapira

❮ Previous
Next ❯

Citations

Nov 6, 2018·CNS & Neurological Disorders Drug Targets·Jia ZhaoJianhui Rong
Oct 27, 2017·Journal of Neuroscience Research·Neeraj Joshi, Sarika Singh
Feb 28, 2018·Current Medicinal Chemistry·Silvia Cerri, Fabio Blandini
Sep 30, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sunisha AryalJohn T Weber
Oct 20, 2020·Frontiers in Cell and Developmental Biology·Alessandra Stacchiotti, Giovanni Corsetti
Jul 12, 2019·Heliyon·Ahmad GhorbaniAzar Hosseini
Aug 1, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Sonat Pınar KaraAysun Unal
Aug 28, 2021·Ecotoxicology and Environmental Safety·Chunnuan ZhangQian Qi

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
flow cytometry
fluorescence activated cell sorter
electrophoresis
confocal microscopy
FACS

Software Mentioned

SPSS

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis